.wp-grid-builder .wpgb-card.wpgb-card-hidden .wpgb-card-wrapper{opacity:1!important;visibility:visible!important;transform:none!important}.wpgb-facet {opacity:1!important;pointer-events:auto!important}.wpgb-facet *:not(.wpgb-pagination-facet){display:none}

Quantification of the Cellular Content of Platelet Rich Plasma Harvested After Injection of Filgrastim Versus Pegfilgrastim Biosimilars: A Prospective, Single Center, Crossover Study

The purpose of this study was to determine if different medications would stimulate changes in the content of a patient’s blood used for platelet-rich plasma injections.

External Collaborators: Mohammadreza Abbasian, Eric Branch, Ali Parsa, Jessica Truett, Joshua J. Cook, Charlkesha A. Rahming, and Adam W. Anz.

Partner Institutions: Andrews Institute Center for Regenerative Medicine

Research Team

Eric A. Branch, MD

Physician

SPECIALTIES:
Knee, Sports Medicine, Elbow, Shoulder

Providers

Orthopedic Specialties

Orthopedic Services

About TOC

Research & Academics

Patient Resources

Quantification of the Cellular Content of Platelet Rich Plasma Harvested After Injection of Filgrastim Versus Pegfilgrastim Biosimilars: A Prospective, Single Center, Crossover Study

Research Team

Providers

Orthopedic Specialties

Orthopedic Services

About TOC

Research & Academics

Patient Resources

Quantification of the Cellular Content of Platelet Rich Plasma Harvested After Injection of Filgrastim Versus Pegfilgrastim Biosimilars: A Prospective, Single Center, Crossover Study

Research Team

Inclement Weather Closures – October 9 & 10, 2026